Skip to content

Akcea therapeutics share price

27.11.2020
Shanberg49335

Akcea Therapeutics Announces Closing of Initial Public ... Jul 19, 2017 · CAMBRIDGE, Mass., July 19, 2017 /PRNewswire/ -- Akcea Therapeutics, Inc. today announced the closing of its initial public offering of 17,968,750 shares common stock at a public offering price of $8.00 per share, including 2,343,750 shares of common stock issued upon full exercise by the underwriters of their option to purchase additional shares. The gross proceeds from the offering … Akcea Therapeutics Inc., AKCA Quick Chart - (NAS) AKCA ... Akcea, Ionis shares halted premarket for news pending MarketWatch. Friday, March 16, 2018. 08:13 AM ET. Akcea Therapeutics price target raised to $30 from $30 at Stifel MarketWatch. Tuesday, February 27, 2018. 07:33 AM ET. Akcea Therapeutics downgraded to … AKCA News Today (Akcea Therapeutics) | MarketBeat The Akcea Therapeutics (NASDAQ:AKCA) Share Price Is Down 41% So Some Shareholders Are Getting Worried finance.yahoo.com - January 17 at 7:32 AM: Akcea and Ionis launch late-stage ATTR cardiomyopathy study seekingalpha.com - January 11 at 6:33 PM: Stock Traders Purchase High Volume of Put Options on Akcea Therapeutics (NASDAQ:AKCA)

Akcea Therapeutics Announces Closing of Initial Public ...

Find the latest Akcea Therapeutics, Inc. (AKCA) stock quote, history, news and other vital information to help you with your stock trading and investing. AKCA | Complete Akcea Therapeutics Inc. stock news by MarketWatch. View real -time stock prices and stock quotes for a full financial overview.

7 Oct 2019 Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target Akcea Shares Sink as Three Top Executives Leave the Biopharma.

AKCA Stock Price & Charts | Akcea Therapeutics In depth view into AKCA (Akcea Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. AKCA - Akcea Therapeutics Stock Price - Barchart.com

In depth view into AKCA (Akcea Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Ticker: AKCA. HEAD-0.10812187194824. Akcea Therapeutics, Inc. is This page includes all SEC registration details as well as a list of all documents  View contact profiles from Akcea Therapeutics Inc. SIC Code 28,283. NAICS Code 32541,5417. Ticker NASDAQ: AKCA. Show More. Drug Manufacturing &  14 Jul 2017 Akcea Therapeutics is joining the parade of biotechs going public, but the company had to cut its stock price and sell more shares in order to  See what employees say it's like to work at Akcea Therapeutics. Salaries, reviews , and more - all posted by employees working at Akcea Therapeutics. Akcea Therapeutics Quote from MotleyFool.com. Glassdoor gives you an inside look at   11 Mar 2020 Akcea Therapeutics (Nasdaq: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals (Nasdaq: IONS), today announced that Lisa  7 Oct 2019 Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target Akcea Shares Sink as Three Top Executives Leave the Biopharma.

Real time Akcea Therapeutics, Inc. (AKCA) stock price quote, stock graph, news & analysis.

Akcea Therapeutics, Inc. - AKCA - Stock Price & News | The ...

dub fx symbol - Proudly Powered by WordPress
Theme by Grace Themes